Variant Fund β 2022 Investments
6 investments dated 2022 Β· listed companies and verified rows first Β· show all
Blackbird Laboratories is a nonprofit life sciences incubator that translates university research breakthroughs into venture-ready biotech companies focused on developing new medicines and enabling technologies.
BiotechDeep TechBaltimore, US
Ben Leventhal(Executive Officer, Director)inMatt Tremblay, PhD(Chief Executive Officer)inEddie Cherok, PhD(Chief Business Officer)in
BoardFred Wilson(Director)inMo Koyfman(Director)inMarguerite Mariscal(Director)
Co-investorsUniversity System of Maryland Momentum FundAmex VenturesAndreessen HorowitzBrooks ReitzCircle VenturesCoinbase Ventures+6 more
DIMO provides vehicle data infrastructure that gives developers a single permissioned API to real-time telemetry, identity, and consent data from over 50 connected vehicle brands.
Data & InfrastructureIoTMobility & Transportation
Yevgeny "Yev" Khessin(CEO & Co-Founder)in
Co-investorsBlueYard CapitalCoinFundConsenSys MeshTaisu VenturesWonder VenturesLattice Capital+4 more
Polygon is a remote psychology practice offering online diagnostic testing for dyslexia, ADHD and other learning differences.
IoTWellness & FitnessBerkeley, US
Co-investorsDorm RoomTechstarsAlameda ResearchAnimoca BrandsDune VenturesElevation Capital+7 more
Shibuya is a platform for discovering and sharing short films, serving filmmakers and audiences interested in independent and grassroots storytelling.
Creator EconomyMedia & Entertainment
Co-investorsa16z cryptoAndreessen Horowitz
Tiger Global Management is a New York investment firm founded in 2001 investing in public and private technology growth companies.
Chase Coleman(Founder)in
Co-investorsMirana VenturesPeakUnion Grove Venture PartnersAlameda ResearchAnimoca BrandsDune Ventures+8 more
Other
Tracked investments with no reachable website or further public details β typically companies that wound down, renamed, or were absorbed.
Rows marked βSEC filingβ are inferred from directors named on the company's SEC Form D β public regulatory data, not a portfolio list published by the firm.






















